Cardiology overview congenital heart disease: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
===Treatment=== | ===Treatment=== | ||
* An atrial septal occluder device can be used. There can be migration or erosion of the device so follow-up is warranted. | * An atrial septal occluder device can be used. There can be migration or erosion of the device so follow-up is warranted. | ||
==Patent Foramen Ovale (PFO)== | ==Patent Foramen Ovale (PFO)== | ||
Revision as of 00:11, 4 November 2011
|
Cardiology Overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Atrial Septal Defect
Treatment
- An atrial septal occluder device can be used. There can be migration or erosion of the device so follow-up is warranted.
Patent Foramen Ovale (PFO)
Treatment
- In the PFO patient who has had their first cryptogenic stroke, the treatment of choice as aspirin.
- The benefit of PFO closure is not well established
- The benefit of Coumadin in the patient with PFO is not well established, and this therapy should be reserved for those patients with atrial fibrillation or venous thromboembolism.
Ventricular Septal Defect
- Small in size defects do not require repair.